Outset Medical, Inc. (OM) Form 8-K — Aug 28, 2026
Outset Medical (Nasdaq: OM) filed an 8-K disclosing that General Counsel John Brottem informed the company of his decision to depart, effective September 11, 2026. The filing states Mr. Brottem is leaving to pursue other professional opportunities and that his departure is not due to any dispute or disagreement with the Company or its management.
Price after filing
1 day: 0.0%7 days: -8.9%30 days: -22.6%
Close on the filing date to close N calendar days later (from $3.94). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.